RR

Ramalingeswar Rao Yellamraju

Active Director Designated Partner DIN 10267942
DIN 10267942 First appointment Aug 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramalingeswar Rao Yellamraju

Data last updated:

Ramalingeswar Rao Yellamraju is a Designated Partner at Vidhu Pharma Solutions Llp (since 2023). The company operates in Paper.

DIN 10267942
Primary Designation Designated Partner
Industry Paper
First Appointment 04 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Aug 20232023Active

Board colleagues of Ramalingeswar Rao Yellamraju

NameDINCompanyDesignation
Ramireddygari Kavitha10267943Vidhu Pharma Solutions LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vidhu Pharma Solutions Llp
Premium access

Shareholding and investment profile for Ramalingeswar Rao Yellamraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramalingeswar Rao Yellamraju

Ramalingeswar Rao Yellamraju currently holds 1 directorship: Vidhu Pharma Solutions Llp (Designated Partner, since 04 Aug 2023).

Ramalingeswar Rao Yellamraju was first appointed on 04 Aug 2023 as Designated Partner at Vidhu Pharma Solutions Llp.

The current boards of Ramalingeswar Rao Yellamraju's companies include Ramireddygari Kavitha (Vidhu Pharma Solutions Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available